Search

Pulse Biosciences Inc

Închisă

SectorSănătate

53.88 6.48

Rezumat

Modificarea prețului

24h

Curent

Minim

49.49

Maxim

53.11

Indicatori cheie

By Trading Economics

Venit

-6.1M

-25M

Vânzări

33K

434K

EPS

-0.36

Marjă de profit

-5,681.336

Angajați

116

EBITDA

-5.8M

-25M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+2.4% upside

Dividende

By Acuity

Următoarele câștiguri

4 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

1.3B

3.9B

Deschiderea anterioară

47.4

Închiderea anterioară

53.88

Sentimentul știrilor

By Acuity

84%

16%

312 / 339 Clasament în Healthcare

Pulse Biosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 sept. 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 sept. 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 sept. 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 sept. 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 sept. 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 sept. 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 sept. 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

8 sept. 2026, 23:31 UTC

Pulse Biosciences Inc shares are higher in after-market trading, recovering significantly and nearing the upper end of their one-month range.

4 sept. 2026, 22:26 UTC

Pulse Biosciences Inc. shares are higher in after-market trading, remaining above their 20-day moving average and near the upper end of their one-month range.

3 sept. 2026, 22:21 UTC

Pulse Biosciences Inc shares are lower in after-market hours amid notable volatility, reversing gains from the previous four sessions without specific news to explain the decline.

2 sept. 2026, 23:41 UTC

Pulse Biosciences Inc shares are higher in after-market hours, recovering from earlier losses amid broader market strength following weaker job growth data from ADP.

1 sept. 2026, 22:51 UTC

Pulse Biosciences Inc shares are higher in after-market trading, following earlier volatility amid macroeconomic pressures and a mixed sentiment in the health care equipment sector.

31 aug. 2026, 20:07 UTC

Pulse Biosciences is trading higher, reflecting broader market gains since Friday. The stock remains above its 20-day moving average and near its one-month range.

29 aug. 2026, 00:01 UTC

Pulse Biosciences Inc shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the top of its one-month range.

28 aug. 2026, 23:46 UTC

Pulse Biosciences Inc is trading lower in after-market hours, with no specific news identified to explain the movement. Broader market conditions may be influencing sentiment.

27 aug. 2026, 20:07 UTC

News

Pulse Biosciences Inc. is higher today, recovering from a prior session decline. Analyst Mike Matson has a Buy rating and $58 price target.

26 aug. 2026, 23:21 UTC

Pulse Biosciences Inc is higher in after-market trading, reflecting a broader market trend. The price remains near the upper end of its one-month range.

25 aug. 2026, 20:07 UTC

Shares of Pulse Biosciences Inc. are lower today, reflecting routine volatility amid a broader market backdrop of declining oil prices and Treasury yields.

24 aug. 2026, 23:36 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a brief peak, amid broader market concerns over geopolitical tensions affecting oil supply.

20 aug. 2026, 20:06 UTC

Pulse Biosciences Inc is higher in Thursday's session, reflecting a broader market trend. The stock is trading above its 20-day moving average.

19 aug. 2026, 19:16 UTC

Pulse Biosciences Inc is trading higher, maintaining gains since Tuesday's close. The stock remains above its 20-day moving average and near its one-month range high.

18 aug. 2026, 19:56 UTC

News

Pulse Biosciences announced inducement grants for new employees, raising potential dilution concerns. Shares are trading lower during Tuesday's session, retracing from an early peak.

17 aug. 2026, 22:36 UTC

Pulse Biosciences Inc shares are trading higher in after-market hours. The stock has gained significantly over the past month, reflecting broader market dynamics.

14 aug. 2026, 19:11 UTC

Pulse Biosciences Inc shares are declining, breaking a trend of higher closes. The broader market reacts to an unexpected decline in U.S. retail sales.

13 aug. 2026, 20:06 UTC

Pulse Biosciences Inc shares are higher, maintaining gains since Wednesday's close despite earlier intraday volatility and no specific news driving the movement.

12 aug. 2026, 20:06 UTC

Pulse Biosciences Inc. shares are lower today, continuing a decline after an early peak. The asset remains above its 20-day moving average.

11 aug. 2026, 23:01 UTC

Pulse Biosciences Inc shares are lower in after-market trading, reversing earlier gains despite being above its 20-day moving average. No specific news was identified.

10 aug. 2026, 21:01 UTC

Pulse Biosciences Inc shares are lower in after-market hours, reflecting no specific news to explain the movement. The asset remains above its 20-day moving average.

7 aug. 2026, 19:51 UTC

News

Pulse Biosciences shares are higher after reporting second-quarter revenue of $434,000 and increasing patient enrollment targets for its pivotal trial.

6 aug. 2026, 22:16 UTC

News

Pulse Biosciences reported a net loss of $24.7 million for Q2 2026. Shares are trading higher after announcing significant progress in its cardiac catheter program.

Comparație

Modificare preț

Pulse Biosciences Inc Așteptări

Obiectiv de preț

By TipRanks

2.4% sus

Prognoză pe 12 luni

Medie 50.8 USD  2.4%

Maxim 73 USD

Minim 35 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPulse Biosciences Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

5

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

312 / 339 Clasament în Sănătate

Sentimentul știrilor

Evidențe foarte puternice de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.